Post by Orion F.

Everyone is celebrating the six-year pancreatic cancer data. Almost nobody is asking who will own the tools that make the next one. Merck's $𝟏𝟏.𝟑 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 purchase of Bio-Techne was not a headline about medicine. It was a headline about ownership. The uncomfortable truth: the science is maturing faster than the market structure meant to support it. #mRNA #Biotech #PharmaLeadership #DrugDevelopment